| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70f4d9874f66c3b7d4738051e49c24fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b3d96321ed45c6f0cc7324369c2682c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a883af4ba5f156d0aa87043cae635df5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5b0ff0a8ad09fbdabde4516118a2340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89df37d2e850aeb16f132954bd35d521 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-4823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765 |
| filingDate |
2012-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a652d32cd448bc84b11814767cbe191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f53699eeb0a4f1442df6b6a30efa194a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1436ca08ef0c897d16260372bb05db3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6bf6e9830e2fff89f1d7173421453ee |
| publicationDate |
2016-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9302013-B2 |
| titleOfInvention |
Active principle for mitigating undesired medical conditions |
| abstract |
A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic center complying with the formula X 1 (—R″—)(—R′) m H n where: a) X 1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) —R″— is a bivalent organic group providing attachment to the carrier via one of its free valences and to X 1 at the other free valence; and d) R′— is a monovalent organic group attached to the X 1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual. |
| priorityDate |
2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |